- Percutaneous EVAR
- Fenestrated EVAR
- Aortic Stents
- TAA Grafts
Aortic Repair Market size was valued at USD x million in 2022 and is poised to grow at a CAGR of 5.7% from 2023-2029. Irregular extension of the aorta in the abdomen of a person is an ordinarily happening aneurysm on the planet. People of any age are helpless because of the frequency of a stomach aortic aneurysm. Agony emerging from such an aneurysm can prompt loss of motion or even cause the passing of the patient through cardiovascular issues, for example, blood vessel stenosis. Endovascular aneurysm repair (EVAR) is an aggregate term for all medications that are coordinated to carefully fix the aortic aneurysm situated in the patient's stomach area. Key players in the aortic repair market have propelled different new products for aortic repair treatment and this has emphatically influenced the development of the aortic repair market. For example, in 2017, Lombard Medical Inc. received approval from the Japanese Ministry of Health, Labor and Welfare for its new IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2016, Lombard Medical, Inc. received CE Mark approval for its IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2013, Lombard Medical Inc. propelled its Aorfix, a most recent endovascular stent join the U.S. showcase. In 2014, Cordis Corporation ( Cardinal Health, Inc.) propelled its INCRAFT Stent Graft System (INCRAFT System), a device for use amid endovascular aneurysm repair (EVAR) for patients experiencing infrarenal. In 2015, Endologix, Inc. got an endorsement from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its AFX Endovascular System for the treatment of stomach aortic aneurysms. In 2014, Medtronic Plc. gotten endorsement for its new Endurant IIs in the U.S. Furthermore, Europe. Endurant IIs is the most recent stent unit framework for the endovascular repair of aortic aneurysms. These approvals have prompted the advancement of novel items in the market, which is relied upon to drive the development of worldwide stomach aortic aneurysm repair gadgets advertised sooner rather than later. Expanding coordinated efforts and securing exercises by key players in the market are likewise anticipated to bolster the development of the worldwide aortic repair market.
Aortic Repair Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.7%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Aortic Repair Market Dynamics
The effect of drivers is currently moderate, however is relied upon to increment in future and drive the aortic repair, inferable from high predominance of stomach aortic aneurysm infection and development in geriatric populace. The effect of limitations is foreseen to diminish amid the figure time frame as government is taking strong endeavors toward change of cost structure of aortic repair devices and treatment techniques. Besides, government is taking activities to expand mindfulness identified with accessibility of aortic repair treatment strategies and gadgets.
Asia-Pacific got significant share
Aortic Repair Market Regional Analysis
Geographically Aortic Repair Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe North America is relied upon to hold a prevailing position in the worldwide aortic repair market, attributable to nearness of top players and successive launch of novel products. For example, in 2015, Cook Group Incorporated launched its most recent Zenith Alpha stomach endovascular unit in Canada. Apex Alpha stomach is demonstrated for endovascular treatment of patients with stomach aortic aneurysm. The Asia Pacific is additionally anticipated that would show high development in the worldwide aortic repair market, inferable from expanding endorsements of novel gadgets by major administrative bodies in the area. For example, in Lombard Medical, Inc. gotten endorsement for its new AorFlex conveyance framework from the Japanese Ministry of Health, Labor and Welfare. AorFlex is a conveyance framework for Aorfix endovascular stent unite demonstrated for the treatment of aortic repair.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Aortic Repair Market Segmentation
By Product Type
By Site
- Infrarenal
- Pararenal
By Anatomy
- Traditional
- Complex
By End User
- Hospitals
- Clinics
- Diagnostic Centres
- Ambulatory Surgical Centres
Frequently Asked Questions
The aortic repair market size was valued at USD x million in 2022
The aortic repair market key players are: Medtronic (U.S.) Edwards Lifesciences (U.S.) Sorin Group (Italy) Abbott Laboratories (U.S.), Admedes Schuessler GmbH (Germany) Accellent Inc. (U.S.) AorTech International (U.K.) Arbor Surgical Technologies, Inc. (U.S.) Boston Scientific (U.S.) CryoLife, Inc. (U.S.) AutoTissue GmbH (Germany) Micro Interventional Devices, Inc. (U.S.) Neovasc, Inc. (Canada) Colibri Heart Valve, LLC (U.S.) Leman Cardiovascular Sa (Switzerland) JenaValve Technology (Germany) MiCardia Corporation (U.S.) On-X Life Technologies, Inc. (U.S.)
The aortic repair market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Aortic Repair Market Introduction |
| 2.1.Global Aortic Repair Market - Taxonomy |
| 2.2.Global Aortic Repair Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Site |
| 2.2.3. Anatomy |
| 2.2.4.End Users |
| 2.2.5.Region |
| 3. Global Aortic Repair Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Aortic Repair Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Aortic Repair Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Percutaneous EVAR |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Fenestrated EVAR |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Aortic Stents |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. TAA Grafts |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Aortic Repair Market By Site, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Infrarenal |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pararenal |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Aortic Repair Market By Anatomy, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Traditional |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Complex |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Aortic Repair Market By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinics |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Centres |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Ambulatory Surgical Centres |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Aortic Repair Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Aortic Repair Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Percutaneous EVAR |
| 10.1.2.Fenestrated EVAR |
| 10.1.3.Aortic Stents |
| 10.1.4.TAA Grafts |
| 10.2. Site Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Infrarenal |
| 10.2.2.Pararenal |
| 10.3. Anatomy Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Traditional |
| 10.3.2.Complex |
| 10.4. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Clinics |
| 10.4.3.Diagnostic Centres |
| 10.4.4.Ambulatory Surgical Centres |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Aortic Repair Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Percutaneous EVAR |
| 11.1.2.Fenestrated EVAR |
| 11.1.3.Aortic Stents |
| 11.1.4.TAA Grafts |
| 11.2. Site Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Infrarenal |
| 11.2.2.Pararenal |
| 11.3. Anatomy Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Traditional |
| 11.3.2.Complex |
| 11.4. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Clinics |
| 11.4.3.Diagnostic Centres |
| 11.4.4.Ambulatory Surgical Centres |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Aortic Repair Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Percutaneous EVAR |
| 12.1.2.Fenestrated EVAR |
| 12.1.3.Aortic Stents |
| 12.1.4.TAA Grafts |
| 12.2. Site Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Infrarenal |
| 12.2.2.Pararenal |
| 12.3. Anatomy Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Traditional |
| 12.3.2.Complex |
| 12.4. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Clinics |
| 12.4.3.Diagnostic Centres |
| 12.4.4.Ambulatory Surgical Centres |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Aortic Repair Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Percutaneous EVAR |
| 13.1.2.Fenestrated EVAR |
| 13.1.3.Aortic Stents |
| 13.1.4.TAA Grafts |
| 13.2. Site Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Infrarenal |
| 13.2.2.Pararenal |
| 13.3. Anatomy Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Traditional |
| 13.3.2.Complex |
| 13.4. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Clinics |
| 13.4.3.Diagnostic Centres |
| 13.4.4.Ambulatory Surgical Centres |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Aortic Repair Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Percutaneous EVAR |
| 14.1.2.Fenestrated EVAR |
| 14.1.3.Aortic Stents |
| 14.1.4.TAA Grafts |
| 14.2. Site Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Infrarenal |
| 14.2.2.Pararenal |
| 14.3. Anatomy Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Traditional |
| 14.3.2.Complex |
| 14.4. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Clinics |
| 14.4.3.Diagnostic Centres |
| 14.4.4.Ambulatory Surgical Centres |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) |
| 15.2.1.Medtronic (U.S.) |
| 15.2.2.Edwards Lifesciences (U.S.) |
| 15.2.3.Sorin Group (Italy) |
| 15.2.4.Abbott Laboratories (U.S.), |
| 15.2.5.Admedes Schuessler GmbH (Germany) |
| 15.2.6.Accellent Inc. (U.S.) |
| 15.2.7.AorTech International (U.K.) |
| 15.2.8.Arbor Surgical Technologies, Inc. (U.S.) |
| 15.2.9.Boston Scientific (U.S.) |
| 15.2.10.CryoLife, Inc. (U.S.) |
| 15.2.11.AutoTissue GmbH (Germany) |
| 15.2.12.Micro Interventional Devices, Inc. (U.S.) |
| 15.2.13.Neovasc, Inc. (Canada) |
| 15.2.14.Colibri Heart Valve, LLC (U.S.) |
| 15.2.15.Leman Cardiovascular Sa (Switzerland) |
| 15.2.16.JenaValve Technology (Germany) |
| 15.2.17.MiCardia Corporation (U.S.) |
| 15.2.18.On-X Life Technologies, Inc. (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Medtronic (U.S.)
- Edwards Lifesciences (U.S.)
- Sorin Group (Italy)
- Abbott Laboratories (U.S.),
- Admedes Schuessler GmbH (Germany)
- Accellent Inc. (U.S.)
- AorTech International (U.K.)
- Arbor Surgical Technologies, Inc. (U.S.)
- Boston Scientific (U.S.)
- CryoLife, Inc. (U.S.)
- AutoTissue GmbH (Germany)
- Micro Interventional Devices, Inc. (U.S.)
- Neovasc, Inc. (Canada)
- Colibri Heart Valve, LLC (U.S.)
- Leman Cardiovascular Sa (Switzerland)
- JenaValve Technology (Germany)
- MiCardia Corporation (U.S.)
- On-X Life Technologies, Inc. (U.S.)